News

Blog y noticias

Glaucoma-banner-blog-QR-1200x675.png
04/Feb/2025

After the success of the first two webinars held in 2024, this year we have great plans to continue learning together, so from Dr+Vet by Andersen we are pleased to announce that next March 4th of 2025, the renowned veterinary ophthalmologist Christian Cabo will be the third speaker of our webinars. Christian, with his extensive experience and, will offer us a complete webinar on the management of glaucoma in small animals.

A complete tour on glaucoma
In this webinar, Christian will guide us through a detailed analysis of glaucoma: from the pathophysiology of the disease to the most effective methods of diagnosis for both general veterinarians and ophthalmologists. He will also discuss the main therapeutic options available, including medical, surgical and neuroprotective treatments for vision preservation. All of this will be accompanied by real clinical cases to illustrate how to put this knowledge into practice in the daily practice.

The Speaker
Christian Cabo has a degree in Veterinary Medicine from the University of León and has focused in veterinary ophthalmology since 2013. After his academic and practical training, he worked for seven years at Visionvet, a reference center in Seville. He also holds a postgraduate diploma in veterinary ophthalmology from the Complutense University of Madrid and is accredited in ophthalmology by AVEPA. Throughout his career, he has authored several publications and has participated as a speaker at national and international congresses. He is a member of several professional societies, such as ESVO, SEOVET and BrAVO, and continues to share his expertise with the veterinary community through workshops and conferences.

Webinar details
Date: March 4th of 2025
Time: 13:00h CET
Duration: 90 minutes (60′ talk + 30′ questions)
Mode: Online

This webinar is an excellent opportunity to learn more about glaucoma and improve the management of this disease in the clinic. If you are a clinical veterinarian, do not miss this opportunity to learn with an expert in the field.

Register now and participate for free!
Don’t miss this training session that promises to be of great value for your daily practice. We look forward to seeing you on March 5th!

[Register here]


Blog-amsterdam-ecvo-3-1200x675.png
07/Oct/2024

Glaucoma in animals is a chronic eye disease that affects both dogs and cats, among other species. It is usually characterized by an increase in intraocular pressure (IOP), which damages the optic nerve and retina, leading to progressive loss of vision and even blindness. As intraocular fluid, known as aqueous humor, accumulates due to a failure of its natural drainage, the pressure inside the eye increases, causing irreversible damage to the internal ocular structures.

The importance of the optic nerve and aqueous humor

The optic nerve is essential in the visual process, since it is responsible for transmitting the images captured by the retina to the brain, where they are processed to generate vision. This nerve is very sensitive to changes in pressure inside the eye. The aqueous humor, on the other hand, is a liquid that flows continuously inside the eye, providing nutrients to the internal ocular structures and eliminating waste. Under normal conditions, this fluid is drained through a specialized system in the iridocorneal angle, but in cases of glaucoma, this outflow is blocked or reduced, causing an accumulation of fluid that raises eye pressure.

There are two main types of glaucoma: primary glaucoma and secondary glaucoma. Primary glaucoma is related to genetic and anatomical causes, being more frequent in predisposed breeds of dogs, such as Cocker Spaniel or Maltese Bichon. Secondary glaucoma, on the other hand, arises as a consequence of other ocular diseases or trauma, such as chronic uveitis, lens dislocation or cataracts. The latter type is more common in cats.

Symptoms of glaucoma in animals

Glaucoma is a difficult disease to detect in its early stages, as animals usually adapt to the gradual loss of vision without showing obvious symptoms. However, as the disease progresses, clinical signs become more evident. Symptoms of glaucoma include:

  • Red eyes
  • Severe eye pain, causing the animal to rub its eyes or avoid light.
  • Dilated pupils that do not respond adequately to light
  • Blurred vision
  • Nausea, vomiting, irritability and behavioral changes due to pain
  • Cloudy appearance or bluish halo in the affected eye
  • Sensitivity to light (photophobia)
  • Disorientation or difficulty moving around in familiar spaces

In more advanced stages, animals may exhibit aggressive behavior or irritability due to severe pain. It is important to remember that animals can adapt to vision loss without noticing it in early stages, so regular veterinary checkups are crucial to detect and treat this disease early.

Diagnosis of glaucoma

Diagnosis of glaucoma requires a thorough ophthalmologic evaluation. The most common tests include tonometry, which measures IOP and determines whether it is within normal limits, and ophthalmoscopy, to assess the condition of the optic nerve and retina. In some cases, gonioscopy may be performed to observe the iridocorneal angle, where the aqueous humor drains, and to determine if there is an obstruction in the flow of this fluid.

Early detection is essential to prevent irreversible damage to the optic nerve and loss of vision. Unfortunately, in many pets glaucoma presents acutely, with obvious symptoms, making intervention urgent.

Treatment of glaucoma in animals

Treatment of glaucoma in animals is aimed at reducing IOP and preventing further vision loss. There are two main approaches: medical treatment and surgical treatment.

  1. Medical treatment: In less severe cases, glaucoma can be managed with medications that reduce the production of aqueous humor or improve its drainage. These medications are usually eye drops, although systemic treatments are also available.
  2. Surgical treatment: When medical treatment is not sufficient, surgery is used. There are two main options:
    • Laser: Used to reduce the production of aqueous humor in the affected eye.
    • Drainage implants: Valves or tubes are placed to allow the aqueous humor to drain out of the eye, reducing internal pressure.

Both treatments are aimed at preventing the progression of glaucoma and preserving vision, although in advanced cases blindness may be inevitable.

Nutraceuticals in the management of glaucoma

Nutraceuticals play a complementary role in the management of glaucoma, helping to protect the optic nerve and improve ocular microcirculation.  Glauco+ from Dr+Vet by AndersenPets is an example of a supplement specially formulated for animals with glaucoma. It contains ingredients such as:

  • Ginkgo biloba, which improves ocular circulation and helps protect the optic nerve from ischemic damage.
  • Vaccinium myrtillus (bilberry), rich in antioxidants that neutralize free radicals and improve ocular blood flow.
  • Citicoline, a neuroprotectant that supports visual function and the central nervous system by protecting retinal ganglion cells from oxidative stress.

The use of these nutraceuticals can help slow the progression of glaucoma and improve the quality of life of affected pets, although they should always be combined with appropriate medical and surgical treatment.

Glaucoma prevention

Since glaucoma can be asymptomatic in its early stages, prevention is key. Genetically predisposed breeds, such as Cocker Spaniel, French Bulldog and Maltese Bichon, should undergo regular ophthalmologic checkups to detect any early signs of the disease. In some cases, veterinarians may prescribe preventive eye drops to lower IOP in pets with a family history of glaucoma.

In general, glaucoma is a disease that requires multidisciplinary management. The combination of medication, surgery and nutraceuticals may offer a better prognosis and preserve vision longer. It is essential that veterinarians watch for clinical signs and educate guardians on the importance of ophthalmologic examinations to detect glaucoma early.


Mida-blog-bonica-gran-1200x675.png
22/May/2024

Veterinary ophthalmology is a complex and constantly evolving field, where research, innovation and collaboration are key to advancing pet eye care.

As passionate as we are about animal welfare and eye health, we are proud to announce our participation as sponsors of the 2024 European Congress of the European Association of Veterinary Ophthalmology (ECVO). This annual event is the epicenter of veterinary ophthalmology in Europe, bringing together the best specialists, researchers and practitioners in the field to share knowledge, present scientific advances and make meaningful connections.

Each year, ECVO hosts its annual congress in a major European city, providing a unique platform for the exchange of ideas, discussion of clinical cases and continuous learning. Over four intense days, the congress covers a wide range of topics related to veterinary ophthalmology, from the presentation of pioneering research to the discussion of innovative surgical techniques.

The 2024 program

The 2024 European Association of Veterinary Ophthalmology (ECVO) Congress promises to be exceptional, with a special focus on exotic animal ophthalmology. Under the theme “Ophthalmology of Exotic Animals,” the continuing education program and master class will explore the anatomical and physiological peculiarities of the eyes of reptiles, birds, rabbits and other exotic animals. Experts from Europe and the United States will share their knowledge on ophthalmological examination, husbandry and handling techniques of these animals. In addition, clinical cases, scientific research and advances in the field will be presented, providing a unique opportunity to learn from leaders in veterinary ophthalmology.

Our Participation in ECVO 2024

As leaders in the field of ophthalmic nutraceuticals, we at Dr+Vet are committed to the advancement of veterinary ophthalmology and the ocular care of our pets. During the congress, we will have the opportunity to present our latest advances in ophthalmological products, share our expertise and establish connections with other professionals in the industry. It is also a good opportunity to get a closer look at our products and we will be happy to introduce you to our range and discuss how they can benefit your patients!

See you at ECVO 2024!


XIII-COV-0865-1200x800.jpg
27/Feb/2024

On February 23rd and 24th, the XII Veterinary Ophthalmology Congress was held in Madrid, organized by SEOVET (Spanish Society of Veterinary Ophthalmology).

This year, for the third consecutive time, Dr+Vet is once again sponsoring the largest Spanish congress of veterinary ophthalmology, the SEOVET. More than 140 specialists in this field gathered to share impressions and learn from great specialists.

This year the pre-congress started on Friday with the presentation of Laura Muñoz (Founder and Medical Director of OCULARVET). This was followed by the first lecture on photography in ophthalmology given by Javier Esteban of Anicura Ocaña and then the second lecture on photography given by Raquel Udiz. Both talks provided the attending veterinarians with interesting tips to improve their imaging technique and clinical data collection.

In the afternoon the congress started with a lot of enthusiasm from all participants and attendees. During the SEOVET we could enjoy presentations given by Eva Abarca (HV Canis de Mallorca), Manolo Villagrasa (COV, HV Puchol de Madrid), Màrian Matas (Memvet de Palma), Paco Simó (IVO de Barcelona), Ángel Ortillés (Anicura Valencia Sur de Valencia) and Fernando Sanz (Visionvet de Sevilla).

The SEOVET management knew how to organize a truly dynamic, educational and entertaining conference where all veterinarians could learn the latest developments in their field and at the same time fully enjoy the company and gastronomy.

Dr+Vet had the opportunity to present directly to a specialized audience the improved version of our products GLAUCO+ and OCCULUS+.

Glauco+

One of our presentations was Glauco+, a nutritional supplement designed to address the progression of glaucoma in pets. The improved formula, which includes neuroprotective and vasodilator components in addition to citicoline, has attracted a great deal of interest from ophthalmology veterinarians who had long been asking for this improvement over the Glauco formula.

Occulus+

We also share the improvements in Occulus+. With the addition of key nutritional elements and an improved formulation with alpha lipoic acid, Occulus+ reinforces its antioxidant effect on the crystalline lens.

This year at Dr+Vet we have no plans to put on the brakes, so we are already looking forward to the next big event: Iberzoo+Propet. See you again at IFEMA Madrid from March 13-15!


Disseny-sense-titol.png
16/Nov/2023

Last week, the Dr+Vet team participated in the AVEPA SEVC congress, where we exchanged opinions and learned from high-level clinical veterinarians and at the same time we were able to share with them the novelties in our catalog:

Glauco+

One of our presentations was Glauco+, a nutritional supplement designed to address the progression of glaucoma in pets. The improved formula, which includes natural components and, most importantly, citicoline, has aroused great interest among ophthalmology veterinarians who had long been asking for this improvement over the Glauco formula.

Occulus+

In our participation in AVEPA SEVC, we also shared the improvements in Occulus+. With the addition of key nutritional elements and an improved formulation, Occulus+ reinforces its antioxidant effect in crystalline lens.

The response we received from the veterinarians who visited our booth was certainly inspiring. It fills us with gratitude to see how our products are received with enthusiasm and appreciation by professionals committed to animal welfare.

We thank all the veterinarians who came by, shared their perspectives and were part of this enriching experience.

See you at AVEPA-SEVC Madrid 2024!


6.-POST-CONGRESSOS.png
07/Nov/2023

Dr+Vet will participate in AVEPA-SEVC 2023, the leading event in the field of general veterinary medicine, which will take place in Barcelona from November 9-11.

During these days we will have the opportunity to connect with professionals from all over the veterinary sector and share our latest innovations in veterinary nutraceuticals.

During this congress we will present our improved formulas in the ophthalmological gamma: Glauco+ and Occulus+. Two products that have been part of Dr+Vet since its inception now receive a plus in composition, adapting to new trends and scientific evidence.

Glauco+: Nutritional Support for Glaucoma
Our Glauco+ product has been enhanced with the addition of citicoline, offering essential nutritional support for pets suffering from glaucoma. By providing nutrients to the retina and optic nerve, Glauco+ aims to aid in neuroprotection in cases of normotensive glaucoma.

Occulus+: Improving Lens Health
Occulus+, with abundant antioxidants in its formula, now features the benefits of alpha lipoic acid, enriching the formula to help animals with cataracts and support overall lens health.

Other product lines
In addition to our ophthalmological line, we will also provide detailed information on our digestive and metabolic gammas, with Glyco, Flavum, Digestum and Colitum products.

AVEPA-SEVC 2023 serves as a platform to interact with professional colleagues and showcase our commitment to innovative veterinary care. Our team will be available to provide detailed information and answer any questions you may have about our products.

Stay tuned for updates and follow us on social media for more details as the event approaches – see you there!
For more information about AVEPA-SEVC 2023, visit the official event website: avepa.org/sevc


2.png
23/Oct/2023

From Dr+Vet we are pleased to announce our improvement in the formula of our classic Glauco, the veterinary nutraceutical focused to provide nutrients to the retina and offer neuroprotection to the optic nerve to prevent its degeneration, very relevant in cases of Glaucoma.

Glaucoma is a progressive optic retinopathy and one of the major causes of blindness in humans, it is characterized by optic nerve degeneration, loss of retinal ganglion cells (RGC) and cause restructuring of nerve tissues, causing visual loss.
The factors causing this condition are diverse and complex. Increased intraocular pressure (IOP) has been identified as one of the main drivers of glaucoma and is also the mainstay in the treatment of this disease, focusing on topical and systemic IOP-lowering treatments. Although even though IOP can be effectively controlled, there are patients whose disease still progresses, causing irreversible vision loss.
It is for this reason that Dr+Vet created Glauco+, a nutritional supplement with several natural components that help to generate positive effects on the retina and offer protection against the progression of this disease. Through the incorporation of Citicoline, a molecule that has demonstrated its potential in studies on neurodegenerative diseases, we are opening a door towards a more complete approach to the management of glaucoma in our pets.

Discovering the Potential of Citicoline
In the constant quest to improve treatments for glaucoma in pets, ophthalmic specialists have played a key role in the evolution of therapeutic options. It is for this reason that the incorporation of citicoline in the Glauco+ formula has been a long-awaited and much-requested addition by these eye health experts. Citicoline has garnered considerable attention in the field of neurodegenerative diseases. Research in human medicine has shown its potential benefits in conditions such as senile dementia, Parkinson’s disease and glaucoma. Its introduction in Glauco+ aims to take advantage of these potential benefits for pets.

Citicoline, also known as cytidine-5′-diphosphocholine, is essential for synthesizing membrane phospholipids, including phosphatidylcholine. This compound participates in several metabolic pathways, playing roles in phospholipid homeostasis, mitochondrial dynamics and neurotransmission, especially in the complex mechanism of visual transmission.
When administered orally, Citicoline is efficiently absorbed in the intestines, being transformed into choline and cytidine in the digestive tract and liver. These compounds cross the blood-brain barrier, becoming precursors of vital metabolites. These include phospholipids, nucleic acids, proteins, sphingomyelin, cardiolipin and acetylcholine, a major neurotransmitter in the cholinergic system that modulates visual processes.
In human clinical studies, the ability of citicoline to counteract glutamate-mediated excitotoxicity and oxidative stress, factors that play a crucial role in glaucoma-associated neuronal damage, has been observed. In addition, its influence on the regulation of neurotransmitters such as dopamine and acetylcholine has been linked to improvements in visual function, which translates into a positive impact on quality of life.

Not only has citicoline been shown to protect damaged retinal ganglion cells, but it also acts to improve mitochondrial function and cell membrane integrity. These effects are particularly relevant in the context of glaucoma, where mitochondrial aging processes and neuronal axon damage are characteristic features of the disease.

The classic Glauco components are still present
The Glauco+ approach is based on the combination of natural components, each with its own unique properties and benefits. These components have been selected to address multiple factors, providing a comprehensive solution.
Ginkgo biloba: Native to Asia, this medicinal plant has been appreciated for its properties in traditional medicine for centuries. The extracts of its leaves are rich in flavonoids and terpenoids, which have shown beneficial effects on blood circulation, reduction of blood viscosity, increase in retinal blood flow and neuroprotection.
Anthocyanins (Vaccinium myrtillus, wild blueberry): These natural pigments, present in fruits and vegetables, help improve blood circulation and show antioxidant action. They have an affinity for vascular tissues and have been recognized as beneficial for eye health. Anthocyanins have been shown to contribute to the normalization of retinal blood flow.
Vitamin B3 (Niacinamide or Nicotinamide): This essential vitamin acts as a precursor to the coenzyme nicotinamide adenine dinucleotide (NAD+), vital for mitochondrial function and energy production in retinal ganglion cells. The decrease in NAD+ levels with age and in neurodegenerative diseases, such as glaucoma, has been documented. Supplementation with vitamin B3 has been shown to be a powerful neuroprotectant, preventing neuronal damage and mitochondrial dysfunction.
Vitamin B9 (folic acid) and Vitamin B12 – These B vitamins play a key role in regulating levels of homocysteine, an amino acid linked to retinal damage. The relationship between elevated homocysteine levels and eye damage has been highlighted in several studies. Taking vitamins B12 and B9, in particular, has been associated with reducing homocysteine levels, which could be beneficial in preventing this form of damage.

New tablet format divisible into 4 parts
With the new format divisible into 4 parts, we offer the possibility of adjusting the dose of Glauco+ according to the individual needs of each pet. This new format makes dosing more personalized and precise than with the old format. Offering the possibility of dosing from 2.5kg onwards.
How to get Glauco+?
To purchase Glauco+, you can obtain it exclusively through veterinary distributors in specialized clinics. This measure guarantees that you receive the product under the guidance and supervision of animal health professionals.

In summary
The inclusion of citicoline in Glauco+ represents a step forward in the search for more complete dietary supplements for the eye health of pets. The support and recommendation of ophthalmologists specialized in ocular health are the basis for the development of new and improved products focused especially on veterinary medicine.

From Dr+Vet we want to remember that Glauco+ will be available from November and that at AVEPA-SEVC we will be presenting the product.


foto-para-dentro-drvet-1200x600.jpg
30/Apr/2023

On April 27th, we had the pleasure of sponsoring an exciting webinar organized by the European Society of Veterinary Ophthalmology (ESVO) on the use of nutraceuticals in veterinary ophthalmic practice. The event, brought together leading professionals in the field and members interested in exploring this very relevant topic.

During the webinar, Dr. Teresa Peña, a renowned expert in veterinary ophthalmology and associate professor at the Autonomous University of Barcelona, gave a keynote lecture on the most commonly used ingredients in veterinary ophthalmology and their role in the treatment of various eye diseases in animals. Dr. Peña delved into the scientific evidence supporting the use of these nutraceuticals, as well as the recommended protocols for their application in daily practice. His vast experience and expertise in the field provided attendees with a clear and detailed view of how these products can benefit the ocular health of our veterinary patients.

The webinar was an invaluable opportunity to learn and share knowledge with colleagues from around the world. It also provided a platform for the exchange of ideas and experiences, thus strengthening our professional community.

If you missed the webinar or simply wish to relive it, we invite you to access the full recording available at the following link:

Don’t miss it!


Copyright by Boothmen Pharma 2023. All rights reserved.